6667 — Mega Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual balance sheet for Mega Genomics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	52.6	208	239	400	518
Net Total Accounts Receivable
Net Total Receivables	115	131	204	191	120
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	184	358	685	619	668
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75.4	62.2	51.1	46.9	94
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	264	454	772	706	797
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	53.1	262	69.8	81.2	114
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	266	277	77.7	87.7	152
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-2.7	176	694	618	645
Total Liabilities & Shareholders' Equity	264	454	772	706	797
Total Common Shares Outstanding